Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus

Clinica Chimica Acta

Volumn 301, Issue 1-2, 2000, Pages 119-134

  Passarelli, Marisa ^a   Shimabukuro, Alice F M ^a   Catanozi, Sérgio ^a   Nakandakare, Edna R ^a   Rocha, Jussara C ^a   Carrilho, Alexandre J F ^a   Quintão, Eder C R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Cholesterol efflux; Diabetes mellitus; Glycation; HDL; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN E; CELL RECEPTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; IODINE 125;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; HUMAN; ISOTOPE LABELING; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMAL; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; GLUCOSE; LIPOPROTEINS, HDL CHOLESTEROL; MACROPHAGES, PERITONEAL; MICE; SUPPORT, NON-U.S. GOV'T;

EID: 0033799869     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00336-3     Document Type: Article

References (49)

1. Brown M.S., Goldstein J. A receptor-mediated pathways for cholesterol homeostasis. Science. 232:1986;34-47.
2. Oram J.F., Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37:1996;2473-2491.
3. von Eckardstein A. Cholesterol efflux from macrophages and other cells. Curr. Opin. Lipidol. 7:1996;308-319.
4. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
5. Czarnecka H., Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 271:1996;2023-2028.
6. Fournier N., Moya M., Burkey B.F., et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J. Lipid Res. 37:1996;1704-1711.
7. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., Schmitz G. Molecular cloning of the human ATP-binding cassete transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Bioph Res Comm. 257:1999;29-33.
8. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 104:1999;25-31.
9. Graham D.L., Oram J.F. Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J. Biol. Chem. 262:1987;7439-7442.
10. Mcknight G.L., Reasoner J., Gilbert T., et al. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267:1992;12131-12141.
11. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
12. Davidson W.S., Rodrigueza W.V., Lund-Katz S., Johnson W.J., Rothblat G.H., Phillips M.C. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270:1995;17106-17113.
13. Hara H., Yokoyama S. Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266:1991;3080-3086.
14. Duel P.B., Oram J.F., Bierman E.L. Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes. 40:1991;377-384.
15. Fievet C., Theret N., Shojaee N., et al. Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM. Diabetes. 41:1992;81-85.
16. Harada L.M., Carvalho M.D.T., Passarelli M., Quintão E.C.R. Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages. Atherosclerosis. 139:1998;65-75.
17. Rifici V.A., Khachadurian A.K. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim. Biophys. Acta. 1229:1996;87-94.
18. Passarelli M., Catanozi S., Nakandakare E.R., et al. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and in vitro glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B containing lipoproteins. Diabetologia. 40:1997;1085-1093.
19. Duell P.B., Oram J.F., Bierman E.L. Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes. 39:1990;1257-1263.
20. Lopes-Virella M.F., Klein R.L., Lyons T.J., Stevenson H.C., Witztum J.L. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes. 37:1988;550-557.
21. Cavallero E., Brites F., Delfly B., et al. Abnormal reverse cholesterol transport in controlled type II diabetic patients Studies on fasting and postprandial LpA-I particles. Arterioscler. Thromb. Vasc. Biol. 15:1995;2130-2135.
22. Bellosta S., Mahley R.W., Sanan D.A., et al. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96:1995;2170-2179.
23. 3. J. Lipid Res. 35:1994;1345-1353.
24. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1995;1345-1353.
25. Bartlett G. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1958;466-468.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. 1 in the rat: effects of lipid transfer protein. J. Lipid Res. 28:1987;257-267.
28. Basu S.K., Goldstein J.L., Anderson R.G.W., Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA. 73:1976;3178-3182.
29. 14C] cholesterol in the rat, with special reference to the ovary. Endocrinology. 117:1985;502-510.
30. McFarlane A.S. In vivo behavior of 131-fibrinogen. J. Clin. Invest. 42:1963;346-347.
31. Parthasarathy S., Steinbrecher U.R., Barnett J., Witztum J.L., Steinberg D. The essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82:1985;3000-3004.
32. Fields R. The rapid determination of amino groups with TNBS. Methods Enzymol. 25:1972;464-468.
33. Bagdade J.D., Ritter M.C., Subbaiah P.V. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 21:1991;161-167.
34. Bagdade J.D., Lane J.T., Subbaiah P.V., Otto M.E., Ritter M.C. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis. 104:1993;69-77.
35. Igau B., Castro G., Clavey V., et al. In vivo glucosylated LpA-I subfraction. Evidence for structural and functional alterations. Artherioscler. Thromb. Vasc. Biol. 7:1997;2830-2836.
36. Lottenberg S.A., Lottenberg A.M., Nunes V.S., McPherson R., Quintão E.C.R. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetics and normal controls. Atherosclerosis. 127:1996;81-90.
37. Fournier N., Myara I., Atger V., Moatti N. Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL). Clin. Chim. Acta. 234:1995;47-61.
38. Gugliucci A., Stahl A.J.C. In vitro glycation of human apolipoprotein A-I reduces its efficiency in lecithin: cholesterol acyltransferase activation. Clin. Chim. Acta. 204:1991;37-42.
39. Ahnadi C.E., Masmoudi T., Berthezène F., Ponsin G. Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 23:1993;459-465.
40. Fielding C.J., Reaven G.M., Fielding P.E. Human noninsulin-dependent diabetes: Identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc. Natl. Acad. Sci. USA. 79:1982;6365-6369.
41. Bagdade J.D., Buchanan W.E., Kuusi T., Taskinen M.R. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis. 10:1990;232-239.
42. Oram J.F., Mendez A.J., Slotte J.P., Johnson T.F. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11:1991;403-414.
43. Slotte J.P., Oram J.F., Bierman E.L. Binding of high density lipoproteins to cell receptor promotes translocation of cholesterol from intracellular membranes to the cell surface. J. Biol. Chem. 262:1987;12904-12907.
44. Sakr S.W., Williams D.L., Stoudt G.W., Phillips M.C., Rothblat G.H. Induction of cellular cholesterol efflux in lipid-free apolipoprotein A-I by cAMP. Biochim. Biophys. Acta. 1438:1999;85-98.
45. Hakamata H., Miyazaki A., Sakai M., Suginohara Y., Sakamoto Y., Horiuchi S. Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 14:1994;1860-1865.
46. Rashidini D.L., Rifice V.A., Schneider S.H., Kachadurian A.K. Glycation of high density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity. Metabolism. 48:1999;139-143.
47. Clay M.A., Barter P.J. Formation of new HDL particles from lipid-free apolipoprotein A-I. J. Lipid Res. 37:1996;1722-1732.
48. Mamo J.C.L., Szeto L., Steiner G. Glycation of very low density lipoprotein from rat plasma impairs its catabolism. Diabetologia. 33:1990;339-345.
49. Witztum J.L., Fisher M., Pietro T., Steibrecher U.P., Elam R.L. Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs. Diabetes. 31:1982;1029-1032.